PharmaCyte Biotech (PMCB)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	20.84 mm	20.84 mm	20.84 mm	20.84 mm	20.84 mm	20.84 mm
Cash burn (monthly)	3.93 mm	4.49 mm	368.69 k	471.12 k	351.58 k	299.12 k
Cash used (since last report)	7.02 mm	8.00 mm	657.93 k	840.72 k	627.40 k	533.79 k
Cash remaining	13.82 mm	12.84 mm	20.18 mm	20.00 mm	20.21 mm	20.31 mm
Runway (months of cash)	3.5	2.9	54.7	42.5	57.5	67.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

PMCB institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4	24	-83.3%
Opened positions	4	22	-81.8%
Closed positions	24	2	+1100.0%
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	61.00 k	2.13 bn	-100.0%
Total shares	32.00	945.87 k	-100.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Anchor Investment Management	27.00	$53.00 k	NEW
Caldwell Sutter Capital	2.00	$4.00 k	NEW
Carolina Wealth Advisors	2.00	$4.00 k	NEW
Huntington National Bank	1.00	$0.00	NEW

Largest transactions	Bought/sold	Change
K2 Principal Fund	-327.50 k	EXIT
Geode Capital Management	-200.28 k	EXIT
Vanguard	-174.60 k	EXIT
Equitec Proprietary Markets	-82.73 k	EXIT
Renaissance Technologies	-43.80 k	EXIT
Susquehanna International	-41.19 k	EXIT
Dimensional Fund Advisors	-24.56 k	EXIT
BLK BlackRock	-21.10 k	EXIT
NTRS Northern Trust	-19.23 k	EXIT
Acadian Asset Management	-3.59 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

PMCB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Apr 24	Wayne Remell Walker	Stock Option Common Stock	Grant	Acquire A	No	No	2.12	38,009	80.58 k	38,009
30 Apr 24	Weinstein Robert	Stock Option Common Stock	Grant	Acquire A	No	No	2.12	38,009	80.58 k	38,009
30 Apr 24	Schechter Jonathan	Stock Option Common Stock	Grant	Acquire A	No	No	2.12	38,009	80.58 k	38,009
30 Apr 24	Michael M Abecassis	Stock Option Common Stock	Grant	Acquire A	No	No	2.12	38,009	80.58 k	38,009

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.